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Indigenous people suffer substantially more end-stage kidney
disease (ESKD), especially Australian Aboriginals. Previous work
suggests causal pathways beginning early in life. No studies
have shown the prevalence of early markers of chronic kidney
disease (CKD) in both Indigenous and non-Indigenous children
or the association with environmental health determinants –
geographic remoteness and socioeconomic disadvantage.
Height, weight, blood pressure, and urinary abnormalities were
measured in age- and gender-matched Aboriginal and
non-Aboriginal children from elementary schools across diverse
areas of New South Wales, Australia. Hematuria was defined as
X25 red blood cells/ll (X1þ ), proteinuria X0.30 g/l (X1þ ),
and albuminuria (by albumin:creatinine) X3.4 mg/mmol.
Remoteness and socioeconomic status were assigned using the
Accessibility and Remoteness Index of Australia and Socio-
Economic Indexes For Areas. From 2002 to 2004, 2266 children
(55% Aboriginal, mean age 8.9 years) were enrolled from 37
elementary schools. Overall prevalence of hematuria was 5.5%,
proteinuria 7.3%, and albuminuria 7.3%. Only baseline
hematuria was more common in Aboriginal children (7.1 versus
3.6%; P¼ 0.002). At 2-year follow-up, 1.2% of Aboriginal children
had persistent hematuria that was no different from
non-Aboriginal children (P¼ 0.60). Socioeconomic disadvantage
and geographical isolation were neither significant nor
consistent risk factors for any marker of CKD. Aboriginal children
have no increase in albuminuria, proteinuria, or persistent
hematuria, which are more important markers for CKD. This
suggests ESKD in Aboriginal people may be preventable during
early adult life.
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Indigenous minorities have almost universally poorer health
outcomes than non-Indigenous majority populations world-
wide. This is particularly true for kidney disease.1–3 Australian
Aboriginal and Torres Strait Islander people (hereafter
referred to as Aboriginal) are eight times more likely to
develop end-stage kidney disease (ESKD) than non-Abori-
ginal people and are 10 years younger on average. They are
only half as likely to be listed for transplantation and have
almost 30% lower graft and 8% lower patient survival 5 years
post-transplantation.1 This pattern of excessive burden due
to increased prevalence and poorer outcomes once ESKD
occurs is also found in the Inuit and Native Canadians in
Canada,2 Native Americans in the USA,3 and in the Maori
people of New Zealand.1
Why Indigenous peoples have such an excess risk of ESKD
is largely unknown. The three main causes of ESKD in
Aboriginal people are diabetic nephropathy, primary glomer-
ulonephritis, and hypertension.4 A much larger proportion of
ESKD in Aboriginal Australians is attributed to diabetic
nephropathy (47%) as compared with non-Aboriginal
Australians (17%); however, the ESKD excess is not explained
solely by differences in diabetic prevalence or comorbidities.1
The causal chain contributing to chronic kidney disease
(CKD) may start at or before birth, with maternal factors,5
low birth weight and reduced nephron mass6,7 rendering the
kidney more vulnerable to diabetes and hypertension.
Marked regional differences in ESKD have been noted
between Aboriginal populations8 and in ethnically homo-
geneous countries such as Japan, suggesting socio-demo-
graphic influences rather than genetic predisposition are
responsible.9 Environmental factors such as isolated living
and socioeconomic disadvantage may play the more
important role in the development of CKD.8
Current knowledge about the risk factors for CKD in
Aboriginal people in Australia is mainly limited to adult-
based research that comes from areas of high remoteness
and socioeconomic disadvantage in Northern Australia. This
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lacks non-Aboriginal control groups or adjustment for
variability in locality and sociodemographics.10 The aims of
our study were to determine whether the increased risk of
CKD in Aboriginal adults is evident in childhood, and to
determine whether environmental health determinants could
explain any difference in observed risk.
RESULTS
Baseline characteristics
From February 2002 to June 2004, 2266 children were
enrolled from 37 elementary schools across New South Wales
(Table 1). There were 1248 (55.1%) Aboriginal and 1018
(44.9%) non-Aboriginal children; 51% were male subjects,
and the mean age was 8.9 years (73.8 years). There were
proportionally more Aboriginal children in the youngest age
group (4–6 years), in the lowest weight s.d. quartile (both
Po0.0001) and in the lowest systolic (Po0.0001) and
diastolic blood pressure quartiles (P¼ 0.02). Aboriginal
children were more likely to live within the categories of
highest isolation and disadvantage, and in the most remote
region (Po0.0001). There were no differences between the
groups for gender, birth weight, height s.d., and body mass
index s.d. quartiles.
Design effect estimates for the impact of cluster sampling
by school were small for all markers of CKD: 1.10 for
hematuria, 1.20 for proteinuria, and 1.28 for albuminuria.
Background prevalence of ESKD from the areas sampled
was 1170 cases per million Aboriginal population compared
with 740 cases per million non-Aboriginal population, with a
relative risk of ESKD in Aboriginal people of 1.58 (1.21–2.00),
P¼ 0.001.
Prevalence of markers of CKD
The overall prevalence of hematuria was 5.5%, proteinuria
7.3%, and albuminuria 7.3% (Table 2).
Risk factors for markers of CKD
Aboriginality. Aboriginal children were more likely to have
hematuria at baseline testing than non-Aboriginal children,
and this association was more significant after adjustment for
environmental health determinants and other covariates
(adjusted odds ratios (OR) 2.25, 95% confidence interval
(CI) 1.37–3.69, P¼ 0.001) (Table 2). Even after adjustment,
there were no differences in the frequency of proteinuria
(adjusted OR 0.93, 95% CI 0.68–1.27, P¼ 0.65) or albumi-
nuria (adjusted OR 1.37, 95% CI 0.93–2.01, P¼ 0.11)
between the Aboriginal and non-Aboriginal children.
Persistent and non-persistent hematuria. At 2-year follow-up,
the overall prevalence of hematuria was 5.4%. At follow-up,
9/731 (1.2%) Aboriginal children had persistent hematuria,
compared with 6/643 (0.9%) non-Aboriginal children
(P¼ 0.60). There was also no difference in the frequency of
persistent and non-persistent hematuria between the Abori-
ginal and non-Aboriginal children (P¼ 0.51).
Geographical isolation. Children from low-mid isolation areas
had a relatively low prevalence of hematuria (unadjusted OR
0.36, 95% CI 0.18–0.71, P¼ 0.002) compared with the least
isolated-referent category, which did not change appreciably
with adjustment; however, there was no evidence of a linear
trend in the association between isolation and frequency of
hematuria (trend P¼ 0.05, non-trend Po0.05) (Table 3).
There was no association between prevalence of proteinuria
and isolation category. There appeared to be an inconsistent
relationship between isolation category and frequency of
albuminuria detected, with the most isolated children having
the lowest prevalence of albuminuria, especially after
adjustment for race and other environmental health deter-
minants (race adjusted OR 0.49, 95% CI 0.26–0.90, P¼ 0.01).
There was, however, no evidence of a linear trend between
isolation and frequency of albuminuria (trend P¼ 0.19).
Social disadvantage. No association between social disad-
vantage categories and markers of CKD was found (Table 4).
There was a trend for higher risk of proteinuria in less
disadvantaged children (P¼ 0.004).
Region. No association between regional categories and
markers of CKD was found. There was an increasing trend in
risk for proteinuria from urban to remote regions (P¼ 0.04),
but deviation from trend was also significant (Po0.05).
There were no interactions found between environmental
health determinants and race, age, gender, or other covariates
in any model.
DISCUSSION
Aboriginal children are no more likely to have early urinary
markers of CKD than non-Aboriginal children. There was a
higher prevalence of hematuria at baseline testing in
Aboriginal children, but there were no differences in the
rates of persistent hematuria between Aboriginal and non-
Aboriginal children. We were unable to show any consistent
clear association between proposed environmental determi-
nants of health – social disadvantage and isolation – and
markers of early CKD. Race is often used incorrectly as a
proxy for many risk factors in health that are indicators of
disadvantage, including geographical remoteness and socio-
economic status.11 We measured all these potential risk
factors in our study and have shown that neither racial nor
environmental risk factors appear predictive of early CKD.
Importantly, the association between environment and
markers of CKD was not altered by adjustment for Aboriginal
status. This is the first study designed to differentiate the
relative contributions of race and environmental health
determinants on early markers of CKD.
Our results are surprising as we expected to find an
increased prevalence of CKD, especially albuminuria, in
Aboriginal children and particularly in remote communities.
This hypothesis is largely based on studies of adult Aboriginal
people. In remote Aboriginal communities in the Northern
Territory of Australia, where the incidence of ESKD is the
highest in Australia and the world (1000–2500 cases per
million population annually), microalbuminuria and overt
albuminuria in Aboriginal adults are highly prevalent (23 and
30%, respectively). Over 1–8 years follow-up, albuminuria
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Table 1 | Baseline sociodemographic and clinical characteristics
All subjects Aboriginal % Non-Aboriginal %
Variable n=2266 % (n=1248) (n=1018) P-value
Gender
Male 1155 51.0 50.8 51.2 0.86
Female 1111 49.0 49.2 48.8
Age groups (years)
4–5.9 211 9.3 11.3 6.8 o0.0001
6–6.9 281 12.4 13.6 10.9
7–7.9 329 14.5 15.2 13.7
8–8.9 337 14.9 14.8 14.9
9–9.9 351 15.5 13.5 18.0
10–10.9 361 15.9 13.8 18.6
11–14.8 396 17.5 17.8 17.1
Birth weight quartiles (g)a
412–2920 217 25.7 29.6 22.1 0.08
2921–3316 210 24.9 23.1 26.4
3317–3685 210 24.9 24.4 25.3
3686–5272 208 24.6 22.9 26.2
Height s.d. quartilesa
4.8–0.7 563 25.1 26.9 22.8 0.12
0.8 –0.1 564 25.1 24.6 25.7
0.2–1.0 558 24.8 24.7 25.0
1.1–4.8 562 25.0 23.8 26.6
Weight s.d. quartilesa
6.6–0.5 560 24.9 28.3 20.8 o0.0001
0.4–0.3 560 24.9 24.3 25.7
0.4–1.2 567 25.2 21.7 29.7
1.3–13.3 559 24.9 25.7 23.9
BMI s.d. quartilesa
4.8–0.8 560 24.9 26.9 22.5 0.08
0.7–0.1 562 25.0 24.0 26.3
0.2–0.7 566 25.2 24.0 26.7
0.8 –6.9 558 24.8 25.1 24.6
Isolation category (ARIA score)
Least isolation (0–1.1) 610 26.9 25.9 28.2 o0.0001
Low-mid isolation (1.2–2.4) 639 28.2 27.2 29.4
High-mid isolation (2.5–4.9) 521 23.0 19.4 27.4
Highest isolation (5.0–14.0) 496 21.9 27.5 15.0
Disadvantage category (SEIFA score)
Least disadvantage (989–1103) 548 24.2 21.9 27.0 o0.0001
Low-mid disadvantage (960–988) 585 25.8 23.0 29.3
High-mid disadvantage (836–960) 576 25.4 26.8 23.8
Highest disadvantage (680–835) 557 24.6 28.4 19.9
Region
Urban 370 16.3 16.1 16.6 o0.0001
South coast 364 16.1 15.4 16.9
North coast 497 21.9 20.8 23.3
Rural 599 26.4 24.4 29.0
Remote 436 19.2 23.3 14.2
Systolic BP quartiles (mm Hg)a
62–92 562 25.1 28.2 21.4 o0.0001
93–100 608 27.2 26.6 27.9
101–108 542 24.2 21.6 27.5
109–170 525 23.5 23.6 23.3
Diastolic BP quartiles (mm Hg)a
28–53 522 23.2 25.6 20.5 0.02
54–58 618 27.6 27.9 27.3
59–64 585 26.2 24.6 28.1
65–98 512 22.9 21.8 24.2
ARIA++, Accessibility and Remoteness Index of Australia; BMI, body mass index; BP, blood pressure; s.d., standard deviation; SEIFA, Socio-Economic Indexes For Areas.
aIndicates where data does not total 2266.
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was strongly predictive of CKD, although this association was
not followed from childhood.10 The current prevalence of
albuminuria (albumin:creatinine43.4 mg/mmol) in those
aged 5–19 years from this community is 7.6%, similar to
the rate seen in our Aboriginal (8.1%) and non-Aboriginal
participants (6.5%).12 However, the lack of non-Aboriginal
control groups and the socioeconomic similarities in these
remote settings forces a presumption of race as the major
contributor. This study has found no significant differences
in albuminuria or proteinuria between Aboriginal and non-
Aboriginal children across New South Wales, even when
controlling for levels of isolation, disadvantage, and region.
From a sociodemographic perspective, when compared with
lower risk determinants, areas of remoteness, high isolation,
and high disadvantage carried no increased risk for CKD in
this cohort.
The higher prevalence of hematuria in the Aboriginal
children, which was even more significantly associated with
race after adjustment for environmental confounders, was
not due to a higher number of menstruating Aboriginal
female subjects as these children were identified at screening
and tested on another occasion. An excess of hematuria in
cross-sectional studies has been found in Aboriginal children
from remote communities with high rates of post-infectious
glomerulonephritis.13 In a population of Aboriginal children
aged 5–19 years screened from remote Northern Territory
communities, the rate of asymptomatic hematuria (7.7%)
was similar to that in our Aboriginal cohort (7.1%) (26). In
non-diabetic Indigenous adults, a higher prevalence of
hematuria has been associated with familial factors,14,15
mesangioproliferative glomerulonephritis,16 and immuno-
globulin A nephropathy.17 In Aboriginal children with
Table 2 | Prevalence of chronic kidney disease markers in aboriginal and non-aboriginal children
Overall Non-Aboriginal (referent category) Aboriginal P-value
Hematuria
Events (%) 122 (5.5) 36 (3.6) 86 (7.1)
Unadjusted OR 1.00 2.02 (1.30–3.13) 0.002
Adjusted ORa 1.00 2.25 (1.37–3.69) 0.001
Proteinuria
Events (%) 161 (7.3) 75 (7.6) 86 (7.0)
Unadjusted OR 1.00 0.93 (0.65–1.32) 0.67
Adjusted ORa 1.00 0.93 (0.68–1.27) 0.65
Albuminuria (ACR mg/mmol)
Events (%) 157 (7.3) 63 (6.5) 94 (8.1)
Unadjusted OR 1.00 1.27 (0.87–1.84) 0.22
Adjusted ORa 1.00 1.37 (0.93–2.01) 0.11
ACR, albumin:creatinine; BMI, body mass index; BP, blood pressure; OR, odds ratios; RBC, red blood cells; s.d., standard deviation.
Definitions: HematuriaX25 RBC per HPF (1+); proteinuriaX0.30 g/L (1+); albuminuria, albumin:creatinine (ACR)X3.4 mg/mmol.
aAdjusted for age, gender, birth weight, height s.d., weight s.d., BMI s.d., systolic BP, diastolic BP, isolation category, disadvantage category, and region.
Table 3 | Association between chronic kidney disease markers and geographical isolation
Lowest isolation (referent category) Low-mid isolation High-mid isolation Highest isolation Trend P-value
Hematuria
Events (%) 34 (5.7) 15 (2.4) 40 (7.9) 33 (6.8) 0.05*
Unadjusted OR 1.00 0.36 (0.18–0.71) 1.26 (0.75–2.10) 1.07 (0.49–2.37)
Adjusted ORa 1.00 0.31 (0.14–0.66) 1.26 (0.73–2.16) 0.99 (0.46–2.16)
Race adjusted ORb 1.00 0.29 (0.13–0.63) 1.31 (0.77–2.23) 0.84 (0.38–1.85)
Proteinuria
Events (%) 41 (6.9) 58 (9.3) 28 (5.5) 34 (7.0) 0.48*
Unadjusted OR 1.00 1.78 (0.89–3.59) 0.96 (0.46–2.00) 1.24 (0.58–2.62)
Adjusted ORa 1.00 1.62 (0.78–3.39) 0.99 (0.46–2.14) 1.16 (0.53–2.55)
Race adjusted ORb 1.00 1.63 (0.78–3.42) 0.99 (0.46–2.13) 1.17 (0.54–2.57)
Albuminuria
Events (%) 45 (7.9) 47 (7.5) 42 (8.3) 23 (5.2) 0.19
Unadjusted OR 1.00 0.82 (0.48–1.40) 0.96 (0.62–1.50) 0.59 (0.27–1.27)
Adjusted ORa 1.00 0.63 (0.35–1.13) 0.87 (0.58–1.31) 0.52 (0.28–0.97)
Race adjusted OR b 1.00 0.62 (0.35–1.11) 0.88 (0.59–1.32) 0.49 (0.26–0.90)
ACR, albumin:creatinine; BMI, body mass index; BP, blood pressure; OR, odds ratios; RBC, red blood cells; s.d., standard deviation.
Definitions: HematuriaX25 RBC per HPF (1+); proteinuriaX0.30 g/l (1+); albuminuria, albumin:creatinine (ACR)X3.4 mg/mmol.*Non-trend Po0.05.
aAdjusted for age, gender, height s.d., weight s.d., BMI s.d., systolic BP, diastolic BP, disadvantage category, and region.
bAdjusted for race, age, gender, height s.d., weight s.d., BMI s.d., systolic BP, diastolic BP, disadvantage category, and region.
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hematuria, ESKD outcomes have not yet been demon-
strated18 and prospective studies are needed. At 2-year
follow-up, there were no differences in the rates of persistent
and non-persistent hematuria between Aboriginal and non-
Aboriginal children.
What are the possible reasons in this study for the lack of
differentiation in risk for CKD between Aboriginal and non-
Aboriginal children from socio-demographically diverse
environments? The study had an adequate sample size; even
with larger numbers any increase in risk would be small. The
precision in risk for albuminuria is already narrowly defined,
with the upper limit of any 95% CI being 2.3. Cluster
sampling bias appeared minimal and adjustment for this bias
made little difference to the summary estimates.
Measurement of the main predictors of risk (Aboriginal
status and categories of isolation, disadvantage, and region)
was performed using standardized systems.19–21 There is
no easy solution to the misclassification bias introduced
when spatially aggregated measures are applied to individual
data, and there is no method available to identify and
measure ecological bias. These standards, however, have
been used reliably in geographically and ethnically similar
population-based samples.8,22 High levels of disadvantage
in some areas of lowest isolation demonstrate the disparities
between environmental determinants of health,23 emphasiz-
ing the importance of using more than one measure,
across urban to very remote regions as we have done. Family
history of CKD and other environmental determinants
such as physician availability are also important potential
predictors, but collection of this information either before
or at the time of testing was not possible. We determined
the regional prevalence of Aboriginal ESKD patients for the
study period to be almost twice as much as non-Aboriginal
ESKD patients. This is consistent with the difference in
ESKD rates for Aboriginal and non-Aboriginal people across
New South Wales.8 This disparity has not been reflected
in our study findings for risk of CKD in Aboriginal children.
These data suggest that CKD in Aboriginal people starts
in later childhood and early adulthood, and that a window of
opportunity for prevention exists.
It is unlikely there was error in recording the outcome,
as measurement of proteinuria was performed using both
standard machine dipstick analysis, but confirmed with
a more precise albumin:creatinine. Early morning protein:-
creatinine correlates well with 24 h urinary protein in
children with normal renal function.24 Spot albumin:creati-
nine has been shown to have very good receiver operator
characteristic curves for detecting pathological albuminuria
at the cutoff used in this study.25 Unfortunately, the test
performance for proteinuria screening tests in low prevalence
populations has not been validated. Semiquantitative, one-off
estimations of urinary protein in children vary according
to posture, exercise, illness, and time of day.25 Measurement
error would have been reduced by repeat testing; however,
this was not possible in this study. Prospective testing
to demonstrate persistent markers is likely to be of more
importance, and we look forward to reporting the results
of prospective testing over 6 years in this cohort.
Have we misclassified or omitted outcome measures for early
CKD? Proteinuria was found to be the strongest risk factor for
ESKD in the largest community-based study of mass screening,
with an adjusted relative risk of 14.9.26 Creatinine measurement
in a healthy pediatric sample is unlikely to be helpful in
determining risk for CKD. Renal ultrasound added little to the
evaluation of high-risk Aboriginal children and adults with
asymptomatic proteinuria or hematuria.12
This study indicates that within New South Wales, there
is no increased risk of early CKD in healthy elementary
Table 4 | Association between chronic kidney disease markers and social disadvantage
Least disadvantage
(referent category)
Low-mid
disadvantage
High-mid
disadvantage
Highest
disadvantage
Trend
p-value
Hematuria
Events (%) 32 (6.0) 25 (4.4) 32 (5.7) 33 (6.0) 0.78
Unadjusted OR 1.00 0.73 (0.28–1.91) 0.95 (0.40–2.24) 0.99 (0.47–2.12)
Adjusted ORa 1.00 0.55 (0.21–1.41) 0.82 (0.35–1.93) 0.76 (0.34–1.72)
Race adjusted ORb 1.00 0.59 (0.22–1.57) 0.79 (0.33–1.91) 0.72 (0.30–1.73)
Proteinuria
Events (%) 53 (9.9) 43 (7.6) 34 (6.0) 31 (5.6) 0.004
Unadjusted OR 1.00 0.75 (0.41–1.39) 0.58 (0.32–1.05) 0.54 (0.27–1.06)
Adjusted ORa 1.00 0.57 (0.21–1.58) 0.53 (0.22–1.28) 0.57 (0.27–1.24)
Race adjusted ORb 0.57 (0.21–1.58) 0.53 (0.22–1.28) 0.58 (0.27–1.23)
Albuminuria
Events (%) 43 (8.1) 42 (7.5) 41 (8.2) 31 (5.6) 0.18
Unadjusted OR 1.00 0.93 (0.53–1.63) 1.02 (0.67–1.57) 0.68 (0.40–1.16)
Adjusted ORa 1.00 0.80 (0.39–1.68) 0.87 (0.46–1.65) 0.68 (0.42–1.11)
Race adjusted OR b 1.00 0.82 (0.38–1.74) 0.86 (0.45–1.66) 0.66 (0.40–1.10)
ACR, albumin:creatinine; BMI, body mass index; BP, blood pressure; OR, odds ratios; s.d., standard deviation.
Definitions: HematuriaX25 RBC per HPF (1+); proteinuriaX0.30 g/L (1+); albuminuria, albumin:creatinine (ACR)X3.4 mg/mmol.
aAdjusted for age, gender, height s.d., weight s.d., BMI s.d., systolic BP, diastolic BP, isolation category, and region.
bAdjusted for race, age, gender, height s.d., weight s.d., BMI s.d., systolic BP, diastolic BP, isolation category, and region.
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school-aged Aboriginal children when compared with non-
Aboriginal children. In addition, the environmental determi-
nants of health measured here are not associated with the
markers for CKD studied in these children. Our findings
suggest, whereas the causal pathways for ESKD in Aboriginal
people may exist in childhood or earlier, an increased risk for
CKD is not yet apparent. There is opportunity for primary
preventative measures addressing health-seeking behaviors,
access to health care, and lifestyle factors such as smoking,
obesity, diet, and alcohol abuse in Aboriginal children and
young adults, and these are likely to make a significant
impact on CKD development.27
These are preliminary findings based upon cross-
sectional data. This information is novel, and has not been
reported previously. Of even greater importance will be the
reporting of the longitudinal data currently being collected
on this cohort. This will provide unique and valuable
information on the natural history of CKD in Aboriginal
and non-Aboriginal children across different levels of socio-
demographic risk.
MATERIALS AND METHODS
Selection of participants
Government-run elementary schools were approached for testing
from urban, coastal, rural, and remote locations across the state of
New South Wales. This state has the highest Aboriginal population
in Australia. Non-government schools (private and denominational)
have very few Aboriginal enrolments, and were not considered for
recruitment. To maximize power, sampling was carried out to obtain
equal numbers of Aboriginal and non-Aboriginal children, and in
similar proportions from urban, coastal, rural, and remote areas. All
elementary schools in remote communities were approached and
other areas were sampled if more than 20 Aboriginal children in the
relevant age range attended.
Aboriginal status was determined using the Australian Bureau of
Statistics best practice recommendations, asking the Standard
Indigenous Question on the consent form ‘Is your child of
Aboriginal or Torres Strait Islander origin?’.19 All Aboriginal children
in the participating elementary schools were offered testing for
height, weight, blood pressure, and urinary dipstick abnormalities.
Non-Aboriginal children were matched for gender and age (nearest
birthday) using class lists. We aimed to recruit equal numbers
of boys and girls, Aboriginal and non-Aboriginal children, and
approximately equal numbers of children from each 12-month-age
group.
Aboriginal community engagement
Consultation with local Aboriginal Medical Services and consent
from community leaders were undertaken before commencement of
the study. Approval was obtained from the Ethics Committees of the
Children’s Hospital at Westmead, the University of Sydney, New
South Wales Area Health Services, and the New South Wales
Department of Education and Training. Informed consent was
obtained for each child and, in accordance with NHMRC Guidelines
for Ethical Conduct in Aboriginal and Torres Strait Islander
Research,28 data were collected onto a standardized form and de-
identified for storage and analysis before being returned to each
community after the study visit. Permission to publish data was also
obtained from each community.
Measurement of markers of CKD and associated risk factors
Markers of CKD measured were hematuria, proteinuria, and
albuminuria. Risk factors known or thought to be associated with
the development of CKD in Aboriginal people were also recorded,
including age, gender, growth parameters, birth weight, blood
pressure, and environmental health determinants: categories of
isolation, disadvantage, and region.
A morning clean catch specimen of urine was collected from
each child, with dipstick analysis for hematuria, proteinuria, and
albuminuria performed at the survey site on fresh specimens using a
Bayer Clinitek 50 machine.29 Leukocytes and nitrites were also
recorded for later adjustment for abnormalities of presumed urinary
tract infection. Girls older than 8 years who were found to have
hematuria were questioned about menses, and, if appropriate,
collection was performed at another time. Follow-up urinalysis was
performed 2 years after baseline testing on all available children, and
the frequency of persistent hematuria (hematuria at baseline and
2 year follow-up) and transient hematuria (hematuria detected at
either baseline or 2 year follow-up) was also ascertained.
Hematuria was defined as X25 red blood cells per microliter
(1þ ), proteinuria as X0.30 g/l (1þ ), and albuminuria as
albumin:creatinineX3.4 mg/mmol.
Standardization of urban, coastal, rural, and remote locality was
made using the Accessibility and Remoteness Index of Australia,
with each subject given an Index score according to their postcode
of residence.20 Using geographical information system capabilities,
distances, services, and population density for each locality are
converted to a continuous variable with values ranging from zero for
high accessibility, to 18 for extreme remoteness.30 Accessibility and
Remoteness Index of Australia values for this NSW study ranged
from 0 to 14, and for categorical analysis the scores were grouped
into quartiles. Isolation categories (and Accessibility and Remote-
ness Index of Australia score range) used were least isolation (0–1.1),
low-mid isolation (1.2–2.4), high-mid isolation (2.5–4.9), and
highest isolation (5.0–14.0). Locality was also classified by region
(in order of increasing remoteness by Accessibility and Remoteness
Index of Australia score): urban, south coast, north coast, rural, and
remote.
To determine the level of social and economic well-being of areas
studied, the Socio-Economic Indexes for Areas 200121 Index of
Disadvantage was applied to subjects at the level of collection district
of residence. This is the smallest geographic area for which the Index
is available. The Index of Disadvantage is a continuous score, and is
based upon characteristics such as low income, lower level of
education, high unemployment, and unskilled jobs. It has been
standardized to a mean of 1000, and a s.d. of 100 across all collection
districts in Australia, that is, 95% of scores are between 800 and
1200. Higher scores indicate higher socioeconomic status and least
disadvantage. For categorical analysis, the scores were grouped into
quartiles: highest disadvantage (680–835), high-mid disadvantage
(836–960), low-mid disadvantage (961–988), and least disadvantage
(989–1103).
Birth weight was provided by the parent/carer by recall or from
the child’s health record. Height was measured in stocking feet to
the nearest 0.1 cm with an SECA 220 telescopic portable stadi-
ometer31 that was calibrated between screening visits. Weight was
measured in stocking feet and in school uniform on digital scales to
the nearest 0.01 kg. Body surface area, body mass index, height, and
weight s.d. z-scores were calculated using an age and sex-adjusted
program.32 Blood pressure was measured on the right arm with the
child sitting, using an aneroid sphygmomanometer and the largest
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cuff to encircle the arm and cover at least three-quarters of the
length of the upper arm.33 In children less than 13 years, diastolic
pressure was measured at the point of muffling (Korotkov 4). For
older children the point of disappearance was used (Korotkov 5).34
For children with diastolic and/or systolic blood pressure greater
than the 90th centile for age and sex, two further blood pressures
were recorded after resting the child, and the lowest blood pressure
according to the systolic reading was recorded in mm Hg.35
Data analysis
Proportions of CKD markers (hematuria, proteinuria, and albumi-
nuria) and associated risk factors (age, gender, birth weight, systolic
and diastolic blood pressure, height s.d., weight s.d., body mass
index s.d., and category of isolation, disadvantage, and region) were
compared between Aboriginal and non-Aboriginal groups using the
w2 test. Rates of persistent and non-persistent (transient) hematuria
were compared between Aboriginal and non-Aboriginal children
using the w2 test. The Mantel extension test was used to determine
linear trends across categories and quartiles. OR for markers of CKD
by isolation category, disadvantage category, and region were
determined using logistic regression, with 95% CIs. Analyses were
adjusted for age, gender, diastolic and systolic blood pressure, height
s.d., weight s.d., body mass index s.d., and categories of isolation,
disadvantage, and region. Where appropriate, analyses were then
further adjusted for Aboriginal race. Adjustment was made in all
analyses for the effect of cluster sampling by school.
The Hosmer and Lemeshow test for goodness of fit was applied
in the multivariate models. Tests for interactions between race,
gender, age, categories of isolation, disadvantage and region, and
other significant variables in the final model were performed.
Significance was set at a Po0.05 for main effects and for
interactions. Statistical analysis was completed using SAS36 and
SPSS software.37
Data on the incidence of ESKD was supplied by the Australia and
New Zealand Dialysis and Transplant Registry to determine the
background prevalence of ESKD in the areas sampled.38 As point
prevalence data are not available from the Registry, we used
incidence data for each postcode for the years 1967–2004 to calculate
ESKD prevalence for Aboriginal and non-Aboriginal people.
Presuming Aboriginal and non-Aboriginal population numbers
accessed from the Australian Bureau of Statistics 2001 census were
relatively stable over these 37 years, prevalence was calculated as
total ESKD events over this time period, divided by the population
and multiplied by the time period.19 This incidence density figure
was multiplied by the duration of disease (approximated at 20 years)
to give point prevalence.
We planned to collect data from 1000 Aboriginal and 1000 non-
Aboriginal children, which were sufficient to detect differences in
prevalence of markers of CKD between the two groups of 2.9 versus
1.1%, 4.0 versus 1.8%, 5.5 versus 2.9 at 80% power for hematuria,
proteinuria, and albuminuria, respectively.
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